nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.22	1	CbGbCtD
Diclofenac—Hair disorder—Hydrochlorothiazide—nephrolithiasis	0.013	0.0424	CcSEcCtD
Diclofenac—Henoch-Schonlein purpura—Hydrochlorothiazide—nephrolithiasis	0.013	0.0424	CcSEcCtD
Diclofenac—TTR—urine—nephrolithiasis	0.0123	0.0711	CbGeAlD
Diclofenac—Bad taste—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0381	CcSEcCtD
Diclofenac—UGT1A1—urine—nephrolithiasis	0.0116	0.0674	CbGeAlD
Diclofenac—SLC22A8—nephron—nephrolithiasis	0.00937	0.0543	CbGeAlD
Diclofenac—SLC22A8—urine—nephrolithiasis	0.00752	0.0436	CbGeAlD
Diclofenac—CYP2C19—urine—nephrolithiasis	0.0063	0.0365	CbGeAlD
Diclofenac—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.00611	0.0199	CcSEcCtD
Diclofenac—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.00562	0.0183	CcSEcCtD
Diclofenac—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00562	0.0183	CcSEcCtD
Diclofenac—PTGS2—nephron—nephrolithiasis	0.00532	0.0308	CbGeAlD
Diclofenac—CYP1A2—urine—nephrolithiasis	0.00515	0.0298	CbGeAlD
Diclofenac—CYP2C9—urine—nephrolithiasis	0.00489	0.0283	CbGeAlD
Diclofenac—Toothache—Hydrochlorothiazide—nephrolithiasis	0.00485	0.0158	CcSEcCtD
Diclofenac—CYP2E1—urine—nephrolithiasis	0.00463	0.0268	CbGeAlD
Diclofenac—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0046	0.015	CcSEcCtD
Diclofenac—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.00442	0.0144	CcSEcCtD
Diclofenac—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.00437	0.0143	CcSEcCtD
Diclofenac—CXCL8—nephron tubule—nephrolithiasis	0.00433	0.0251	CbGeAlD
Diclofenac—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00429	0.014	CcSEcCtD
Diclofenac—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00429	0.014	CcSEcCtD
Diclofenac—PLA2G2A—renal system—nephrolithiasis	0.00397	0.023	CbGeAlD
Diclofenac—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00386	0.0126	CcSEcCtD
Diclofenac—PLA2G2A—kidney—nephrolithiasis	0.00384	0.0223	CbGeAlD
Diclofenac—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00376	0.0123	CcSEcCtD
Diclofenac—CYP3A4—urine—nephrolithiasis	0.00373	0.0216	CbGeAlD
Diclofenac—Stinging—Hydrochlorothiazide—nephrolithiasis	0.00364	0.0119	CcSEcCtD
Diclofenac—SLC22A11—nephron tubule—nephrolithiasis	0.00359	0.0208	CbGeAlD
Diclofenac—SLC22A6—nephron tubule—nephrolithiasis	0.00338	0.0196	CbGeAlD
Diclofenac—SLCO1C1—renal system—nephrolithiasis	0.00336	0.0195	CbGeAlD
Diclofenac—UGT2B7—renal system—nephrolithiasis	0.00334	0.0194	CbGeAlD
Diclofenac—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00329	0.0107	CcSEcCtD
Diclofenac—SLC22A11—renal system—nephrolithiasis	0.00326	0.0189	CbGeAlD
Diclofenac—SLCO1C1—kidney—nephrolithiasis	0.00324	0.0188	CbGeAlD
Diclofenac—UGT2B7—kidney—nephrolithiasis	0.00323	0.0188	CbGeAlD
Diclofenac—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00318	0.0104	CcSEcCtD
Diclofenac—Gout—Hydrochlorothiazide—nephrolithiasis	0.00316	0.0103	CcSEcCtD
Diclofenac—SLC22A11—kidney—nephrolithiasis	0.00315	0.0183	CbGeAlD
Diclofenac—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00312	0.0102	CcSEcCtD
Diclofenac—SCN4A—renal system—nephrolithiasis	0.00308	0.0179	CbGeAlD
Diclofenac—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0101	CcSEcCtD
Diclofenac—SLC22A11—cortex of kidney—nephrolithiasis	0.00307	0.0178	CbGeAlD
Diclofenac—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00987	CcSEcCtD
Diclofenac—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00981	CcSEcCtD
Diclofenac—TTR—renal system—nephrolithiasis	0.003	0.0174	CbGeAlD
Diclofenac—SCN4A—kidney—nephrolithiasis	0.00298	0.0173	CbGeAlD
Diclofenac—TTR—kidney—nephrolithiasis	0.0029	0.0168	CbGeAlD
Diclofenac—SLC22A6—cortex of kidney—nephrolithiasis	0.00289	0.0168	CbGeAlD
Diclofenac—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00935	CcSEcCtD
Diclofenac—UGT1A1—renal system—nephrolithiasis	0.00284	0.0165	CbGeAlD
Diclofenac—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00904	CcSEcCtD
Diclofenac—UGT1A1—kidney—nephrolithiasis	0.00275	0.0159	CbGeAlD
Diclofenac—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0027	0.0088	CcSEcCtD
Diclofenac—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00871	CcSEcCtD
Diclofenac—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00871	CcSEcCtD
Diclofenac—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00808	CcSEcCtD
Diclofenac—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00796	CcSEcCtD
Diclofenac—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00796	CcSEcCtD
Diclofenac—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00792	CcSEcCtD
Diclofenac—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00789	CcSEcCtD
Diclofenac—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00782	CcSEcCtD
Diclofenac—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00774	CcSEcCtD
Diclofenac—Injury—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00761	CcSEcCtD
Diclofenac—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00741	CcSEcCtD
Diclofenac—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00226	0.00738	CcSEcCtD
Diclofenac—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00735	CcSEcCtD
Diclofenac—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00735	CcSEcCtD
Diclofenac—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00222	0.00725	CcSEcCtD
Diclofenac—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00221	0.00719	CcSEcCtD
Diclofenac—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00699	CcSEcCtD
Diclofenac—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00699	CcSEcCtD
Diclofenac—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00688	CcSEcCtD
Diclofenac—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00675	CcSEcCtD
Diclofenac—ABCC4—nephron tubule—nephrolithiasis	0.00204	0.0118	CbGeAlD
Diclofenac—SLC22A8—nephron tubule—nephrolithiasis	0.00202	0.0117	CbGeAlD
Diclofenac—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00201	0.00655	CcSEcCtD
Diclofenac—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00641	CcSEcCtD
Diclofenac—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00639	CcSEcCtD
Diclofenac—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00193	0.0063	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00193	0.0063	CcSEcCtD
Diclofenac—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00193	0.0063	CcSEcCtD
Diclofenac—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00619	CcSEcCtD
Diclofenac—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00617	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00617	CcSEcCtD
Diclofenac—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00608	CcSEcCtD
Diclofenac—ABCC4—renal system—nephrolithiasis	0.00185	0.0107	CbGeAlD
Diclofenac—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00604	CcSEcCtD
Diclofenac—SLC22A8—renal system—nephrolithiasis	0.00184	0.0107	CbGeAlD
Diclofenac—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00592	CcSEcCtD
Diclofenac—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00589	CcSEcCtD
Diclofenac—ABCC4—kidney—nephrolithiasis	0.00179	0.0104	CbGeAlD
Diclofenac—SLC22A8—kidney—nephrolithiasis	0.00178	0.0103	CbGeAlD
Diclofenac—ABCC4—cortex of kidney—nephrolithiasis	0.00175	0.0101	CbGeAlD
Diclofenac—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00565	CcSEcCtD
Diclofenac—SLC22A8—cortex of kidney—nephrolithiasis	0.00173	0.01	CbGeAlD
Diclofenac—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00562	CcSEcCtD
Diclofenac—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00558	CcSEcCtD
Diclofenac—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00557	CcSEcCtD
Diclofenac—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00552	CcSEcCtD
Diclofenac—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00169	0.0055	CcSEcCtD
Diclofenac—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00545	CcSEcCtD
Diclofenac—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00542	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00534	CcSEcCtD
Diclofenac—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00531	CcSEcCtD
Diclofenac—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0053	CcSEcCtD
Diclofenac—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00162	0.00528	CcSEcCtD
Diclofenac—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00162	0.00528	CcSEcCtD
Diclofenac—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00525	CcSEcCtD
Diclofenac—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00524	CcSEcCtD
Diclofenac—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00524	CcSEcCtD
Diclofenac—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00158	0.00517	CcSEcCtD
Diclofenac—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00514	CcSEcCtD
Diclofenac—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00508	CcSEcCtD
Diclofenac—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00155	0.00505	CcSEcCtD
Diclofenac—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00503	CcSEcCtD
Diclofenac—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00151	0.00492	CcSEcCtD
Diclofenac—ABCC1—cortex of kidney—nephrolithiasis	0.00149	0.00863	CbGeAlD
Diclofenac—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00485	CcSEcCtD
Diclofenac—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00484	CcSEcCtD
Diclofenac—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00481	CcSEcCtD
Diclofenac—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00147	0.0048	CcSEcCtD
Diclofenac—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00476	CcSEcCtD
Diclofenac—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00466	CcSEcCtD
Diclofenac—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0014	0.00457	CcSEcCtD
Diclofenac—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00138	0.00451	CcSEcCtD
Diclofenac—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00138	0.00449	CcSEcCtD
Diclofenac—CYP2C8—renal system—nephrolithiasis	0.00135	0.0078	CbGeAlD
Diclofenac—CYP2B6—nephron tubule—nephrolithiasis	0.00133	0.0077	CbGeAlD
Diclofenac—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00132	0.00432	CcSEcCtD
Diclofenac—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00427	CcSEcCtD
Diclofenac—CYP2C8—kidney—nephrolithiasis	0.0013	0.00754	CbGeAlD
Diclofenac—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00129	0.00421	CcSEcCtD
Diclofenac—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00415	CcSEcCtD
Diclofenac—Tension—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00413	CcSEcCtD
Diclofenac—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00126	0.00412	CcSEcCtD
Diclofenac—CYP1A2—renal system—nephrolithiasis	0.00126	0.0073	CbGeAlD
Diclofenac—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00125	0.00409	CcSEcCtD
Diclofenac—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00125	0.00407	CcSEcCtD
Diclofenac—CYP2E1—nephron tubule—nephrolithiasis	0.00125	0.00723	CbGeAlD
Diclofenac—CYP1A1—renal system—nephrolithiasis	0.00124	0.0072	CbGeAlD
Diclofenac—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00124	0.00405	CcSEcCtD
Diclofenac—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00122	0.00397	CcSEcCtD
Diclofenac—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00121	0.00394	CcSEcCtD
Diclofenac—CYP2B6—renal system—nephrolithiasis	0.00121	0.007	CbGeAlD
Diclofenac—CYP1A1—kidney—nephrolithiasis	0.0012	0.00696	CbGeAlD
Diclofenac—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0012	0.00391	CcSEcCtD
Diclofenac—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00389	CcSEcCtD
Diclofenac—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00387	CcSEcCtD
Diclofenac—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00118	0.00385	CcSEcCtD
Diclofenac—CYP2B6—kidney—nephrolithiasis	0.00117	0.00677	CbGeAlD
Diclofenac—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0038	CcSEcCtD
Diclofenac—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00378	CcSEcCtD
Diclofenac—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00378	CcSEcCtD
Diclofenac—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00377	CcSEcCtD
Diclofenac—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00372	CcSEcCtD
Diclofenac—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00113	0.0037	CcSEcCtD
Diclofenac—CYP2E1—renal system—nephrolithiasis	0.00113	0.00657	CbGeAlD
Diclofenac—Cough—Hydrochlorothiazide—nephrolithiasis	0.00113	0.00367	CcSEcCtD
Diclofenac—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00358	CcSEcCtD
Diclofenac—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00358	CcSEcCtD
Diclofenac—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00358	CcSEcCtD
Diclofenac—CYP2E1—kidney—nephrolithiasis	0.0011	0.00635	CbGeAlD
Diclofenac—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00357	CcSEcCtD
Diclofenac—PTGS1—renal system—nephrolithiasis	0.00109	0.00633	CbGeAlD
Diclofenac—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00354	CcSEcCtD
Diclofenac—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00351	CcSEcCtD
Diclofenac—CYP2E1—cortex of kidney—nephrolithiasis	0.00107	0.00619	CbGeAlD
Diclofenac—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00346	CcSEcCtD
Diclofenac—PTGS1—kidney—nephrolithiasis	0.00105	0.00612	CbGeAlD
Diclofenac—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00344	CcSEcCtD
Diclofenac—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00344	CcSEcCtD
Diclofenac—PTGS2—renal system—nephrolithiasis	0.00104	0.00605	CbGeAlD
Diclofenac—Shock—Hydrochlorothiazide—nephrolithiasis	0.00104	0.00338	CcSEcCtD
Diclofenac—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00336	CcSEcCtD
Diclofenac—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00335	CcSEcCtD
Diclofenac—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00332	CcSEcCtD
Diclofenac—PTGS2—kidney—nephrolithiasis	0.00101	0.00585	CbGeAlD
Diclofenac—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.001	0.00328	CcSEcCtD
Diclofenac—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000984	0.00321	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00096	0.00313	CcSEcCtD
Diclofenac—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000953	0.00311	CcSEcCtD
Diclofenac—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000946	0.00309	CcSEcCtD
Diclofenac—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000939	0.00306	CcSEcCtD
Diclofenac—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000937	0.00305	CcSEcCtD
Diclofenac—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000927	0.00302	CcSEcCtD
Diclofenac—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000916	0.00299	CcSEcCtD
Diclofenac—CYP3A4—renal system—nephrolithiasis	0.000911	0.00529	CbGeAlD
Diclofenac—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000908	0.00296	CcSEcCtD
Diclofenac—Pain—Hydrochlorothiazide—nephrolithiasis	0.000901	0.00294	CcSEcCtD
Diclofenac—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000901	0.00294	CcSEcCtD
Diclofenac—CYP3A4—kidney—nephrolithiasis	0.000881	0.00511	CbGeAlD
Diclofenac—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000868	0.00283	CcSEcCtD
Diclofenac—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000861	0.00281	CcSEcCtD
Diclofenac—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000837	0.00273	CcSEcCtD
Diclofenac—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000833	0.00272	CcSEcCtD
Diclofenac—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000833	0.00272	CcSEcCtD
Diclofenac—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000776	0.00253	CcSEcCtD
Diclofenac—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000756	0.00247	CcSEcCtD
Diclofenac—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000745	0.00243	CcSEcCtD
Diclofenac—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000721	0.00235	CcSEcCtD
Diclofenac—ABCB1—nephron tubule—nephrolithiasis	0.00071	0.00412	CbGeAlD
Diclofenac—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000697	0.00227	CcSEcCtD
Diclofenac—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00067	0.00218	CcSEcCtD
Diclofenac—Rash—Hydrochlorothiazide—nephrolithiasis	0.000664	0.00217	CcSEcCtD
Diclofenac—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000664	0.00216	CcSEcCtD
Diclofenac—Headache—Hydrochlorothiazide—nephrolithiasis	0.00066	0.00215	CcSEcCtD
Diclofenac—ABCB1—renal system—nephrolithiasis	0.000645	0.00374	CbGeAlD
Diclofenac—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000626	0.00204	CcSEcCtD
Diclofenac—ABCB1—kidney—nephrolithiasis	0.000624	0.00362	CbGeAlD
Diclofenac—ABCB1—cortex of kidney—nephrolithiasis	0.000607	0.00352	CbGeAlD
Diclofenac—ABCC4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000523	0.00174	CbGpPWpGaD
Diclofenac—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000515	0.00171	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000511	0.0017	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000511	0.0017	CbGpPWpGaD
Diclofenac—SLCO1C1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0005	0.00166	CbGpPWpGaD
Diclofenac—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.0005	0.00166	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000499	0.00166	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000499	0.00166	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.000498	0.00165	CbGpPWpGaD
Diclofenac—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.000496	0.00165	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000496	0.00165	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000496	0.00165	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—RGS14—nephrolithiasis	0.000493	0.00164	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000489	0.00163	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000489	0.00163	CbGpPWpGaD
Diclofenac—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.000486	0.00162	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000479	0.00159	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000479	0.00159	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000471	0.00156	CbGpPWpGaD
Diclofenac—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000466	0.00155	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—GRHPR—nephrolithiasis	0.000461	0.00153	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000461	0.00153	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000461	0.00153	CbGpPWpGaD
Diclofenac—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.000458	0.00152	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000456	0.00151	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000449	0.00149	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000436	0.00145	CbGpPWpGaD
Diclofenac—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000426	0.00142	CbGpPWpGaD
Diclofenac—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000426	0.00142	CbGpPWpGaD
Diclofenac—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.00042	0.0014	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000417	0.00138	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000417	0.00138	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—RGS14—nephrolithiasis	0.000415	0.00138	CbGpPWpGaD
Diclofenac—CXCL8—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.000414	0.00137	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AGXT—nephrolithiasis	0.000411	0.00137	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000411	0.00137	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000411	0.00137	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—PTH—nephrolithiasis	0.00041	0.00136	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000408	0.00135	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000399	0.00133	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000399	0.00133	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ADCY10—nephrolithiasis	0.00039	0.0013	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000378	0.00126	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000378	0.00126	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—RGS14—nephrolithiasis	0.000377	0.00125	CbGpPWpGaD
Diclofenac—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000375	0.00125	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—PTH—nephrolithiasis	0.000373	0.00124	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—SPP1—nephrolithiasis	0.000369	0.00123	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000363	0.0012	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000363	0.0012	CbGpPWpGaD
Diclofenac—TTR—Disease—SLC26A1—nephrolithiasis	0.000359	0.00119	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—CHRM3—nephrolithiasis	0.000358	0.00119	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000352	0.00117	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000352	0.00117	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—APRT—nephrolithiasis	0.00035	0.00116	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—SLC26A1—nephrolithiasis	0.00035	0.00116	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—SLC7A9—nephrolithiasis	0.000347	0.00115	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—DGKH—nephrolithiasis	0.000347	0.00115	CbGpPWpGaD
Diclofenac—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000342	0.00114	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GRHPR—nephrolithiasis	0.000339	0.00112	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000337	0.00112	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000337	0.00112	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—DGKH—nephrolithiasis	0.000333	0.00111	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000333	0.00111	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—RGS14—nephrolithiasis	0.000332	0.0011	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000329	0.00109	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—PTH—nephrolithiasis	0.000328	0.00109	CbGpPWpGaD
Diclofenac—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000323	0.00107	CbGpPWpGaD
Diclofenac—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000323	0.00107	CbGpPWpGaD
Diclofenac—TTR—Disease—ATP6V0A4—nephrolithiasis	0.00032	0.00106	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000316	0.00105	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000316	0.00105	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000314	0.00104	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000314	0.00104	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000305	0.00101	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000302	0.001	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000302	0.001	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AGXT—nephrolithiasis	0.000302	0.001	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000301	0.000998	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000301	0.000998	CbGpPWpGaD
Diclofenac—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0003	0.000998	CbGpPWpGaD
Diclofenac—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0003	0.000998	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000294	0.000975	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000294	0.000975	CbGpPWpGaD
Diclofenac—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000292	0.000971	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000281	0.000934	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000281	0.000934	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—DGKH—nephrolithiasis	0.00028	0.000931	CbGpPWpGaD
Diclofenac—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000268	0.000889	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000266	0.000883	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000266	0.000883	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ADCY10—nephrolithiasis	0.000262	0.000869	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000262	0.000869	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000262	0.000869	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—SLC26A1—nephrolithiasis	0.000257	0.000852	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—APRT—nephrolithiasis	0.000257	0.000852	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—DGKH—nephrolithiasis	0.000254	0.000845	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000251	0.000833	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00025	0.000832	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00025	0.000832	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AQP1—nephrolithiasis	0.000249	0.000828	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CHRM3—nephrolithiasis	0.000241	0.0008	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00024	0.000798	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000237	0.000787	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000233	0.000773	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000233	0.000773	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GRHPR—nephrolithiasis	0.000228	0.000757	CbGpPWpGaD
Diclofenac—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000226	0.000749	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—CHRM3—nephrolithiasis	0.000225	0.000748	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000224	0.000744	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—DGKH—nephrolithiasis	0.000224	0.000744	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RGS14—nephrolithiasis	0.000223	0.000739	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.000222	0.000736	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—PTH—nephrolithiasis	0.00022	0.000731	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000217	0.000719	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000217	0.000719	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000209	0.000695	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000207	0.000689	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AGXT—nephrolithiasis	0.000203	0.000675	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000203	0.000673	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0002	0.000665	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.000198	0.000656	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00019	0.00063	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00019	0.00063	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—PTH—nephrolithiasis	0.000185	0.000615	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—CHRM3—nephrolithiasis	0.000184	0.000611	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AQP1—nephrolithiasis	0.000183	0.000607	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GRHPR—nephrolithiasis	0.00018	0.000598	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GRHPR—nephrolithiasis	0.000174	0.000577	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—APRT—nephrolithiasis	0.000173	0.000574	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—SLC26A1—nephrolithiasis	0.000173	0.000574	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PTH—nephrolithiasis	0.000168	0.000559	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—APRT—nephrolithiasis	0.000168	0.000558	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.000168	0.000558	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CHRM3—nephrolithiasis	0.000165	0.000549	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000164	0.000545	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000164	0.000545	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CHRM3—nephrolithiasis	0.000162	0.000538	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AGXT—nephrolithiasis	0.000161	0.000533	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SLC26A1—nephrolithiasis	0.000157	0.000522	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—DGKH—nephrolithiasis	0.000157	0.000522	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000157	0.000522	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AGXT—nephrolithiasis	0.000155	0.000514	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000153	0.000507	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000153	0.000507	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00015	0.000499	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—DGKH—nephrolithiasis	0.00015	0.000499	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PTH—nephrolithiasis	0.000148	0.000492	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000147	0.000488	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000144	0.000478	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000144	0.000478	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ATP6V0A4—nephrolithiasis	0.00014	0.000465	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—APRT—nephrolithiasis	0.000137	0.000453	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—SLC26A1—nephrolithiasis	0.000137	0.000453	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000136	0.000452	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000136	0.000452	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000134	0.000444	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000134	0.000444	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—SLC26A1—nephrolithiasis	0.000132	0.000437	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—APRT—nephrolithiasis	0.000132	0.000437	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AGXT—nephrolithiasis	0.000131	0.000435	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AQP1—nephrolithiasis	0.000123	0.000409	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.00012	0.000398	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000119	0.000396	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000119	0.000396	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GRHPR—nephrolithiasis	0.000117	0.000387	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.000112	0.000372	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.000111	0.00037	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—APRT—nephrolithiasis	0.000111	0.00037	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CHRM3—nephrolithiasis	0.000111	0.00037	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—SPP1—nephrolithiasis	0.000111	0.000367	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.00011	0.000364	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000109	0.000361	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CHRM3—nephrolithiasis	0.000109	0.000361	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.000108	0.00036	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SLC26A1—nephrolithiasis	0.000105	0.00035	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AGXT—nephrolithiasis	0.000104	0.000345	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000103	0.000344	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AGXT—nephrolithiasis	9.99e-05	0.000332	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTH—nephrolithiasis	9.94e-05	0.00033	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AGXT—nephrolithiasis	9.78e-05	0.000325	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AQP1—nephrolithiasis	9.73e-05	0.000323	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	9.53e-05	0.000316	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GRHPR—nephrolithiasis	9.48e-05	0.000315	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GRHPR—nephrolithiasis	9.43e-05	0.000313	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ATP6V0A4—nephrolithiasis	9.4e-05	0.000312	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AQP1—nephrolithiasis	9.38e-05	0.000312	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AGXT—nephrolithiasis	9.22e-05	0.000306	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—APRT—nephrolithiasis	8.83e-05	0.000293	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—SLC26A1—nephrolithiasis	8.83e-05	0.000293	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CHRM3—nephrolithiasis	8.8e-05	0.000292	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—APRT—nephrolithiasis	8.49e-05	0.000282	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	8.49e-05	0.000282	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CHRM3—nephrolithiasis	8.48e-05	0.000282	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GRHPR—nephrolithiasis	8.47e-05	0.000281	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AGXT—nephrolithiasis	8.45e-05	0.000281	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AGXT—nephrolithiasis	8.41e-05	0.000279	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	8.32e-05	0.000276	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—APRT—nephrolithiasis	8.32e-05	0.000276	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GRHPR—nephrolithiasis	8.26e-05	0.000274	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AQP1—nephrolithiasis	7.93e-05	0.000263	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	7.84e-05	0.00026	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—APRT—nephrolithiasis	7.84e-05	0.00026	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GRHPR—nephrolithiasis	7.72e-05	0.000256	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AGXT—nephrolithiasis	7.55e-05	0.000251	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SPP1—nephrolithiasis	7.44e-05	0.000247	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AGXT—nephrolithiasis	7.37e-05	0.000245	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	7.19e-05	0.000239	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APRT—nephrolithiasis	7.19e-05	0.000239	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CHRM3—nephrolithiasis	7.17e-05	0.000238	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SLC26A1—nephrolithiasis	7.15e-05	0.000237	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APRT—nephrolithiasis	7.15e-05	0.000237	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AGXT—nephrolithiasis	6.88e-05	0.000229	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GRHPR—nephrolithiasis	6.6e-05	0.000219	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APRT—nephrolithiasis	6.42e-05	0.000213	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	6.42e-05	0.000213	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AQP1—nephrolithiasis	6.29e-05	0.000209	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC26A1—nephrolithiasis	6.26e-05	0.000208	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APRT—nephrolithiasis	6.26e-05	0.000208	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AQP1—nephrolithiasis	6.05e-05	0.000201	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AQP1—nephrolithiasis	5.93e-05	0.000197	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AGXT—nephrolithiasis	5.88e-05	0.000195	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APRT—nephrolithiasis	5.85e-05	0.000194	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	5.85e-05	0.000194	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CHRM3—nephrolithiasis	5.69e-05	0.000189	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AQP1—nephrolithiasis	5.59e-05	0.000186	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CHRM3—nephrolithiasis	5.47e-05	0.000182	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CHRM3—nephrolithiasis	5.36e-05	0.000178	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AQP1—nephrolithiasis	5.12e-05	0.00017	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AQP1—nephrolithiasis	5.09e-05	0.000169	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GRHPR—nephrolithiasis	5.09e-05	0.000169	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CHRM3—nephrolithiasis	5.05e-05	0.000168	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	5e-05	0.000166	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APRT—nephrolithiasis	5e-05	0.000166	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SPP1—nephrolithiasis	4.99e-05	0.000166	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CHRM3—nephrolithiasis	4.63e-05	0.000154	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CHRM3—nephrolithiasis	4.61e-05	0.000153	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AQP1—nephrolithiasis	4.57e-05	0.000152	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AGXT—nephrolithiasis	4.54e-05	0.000151	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AQP1—nephrolithiasis	4.46e-05	0.000148	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AQP1—nephrolithiasis	4.17e-05	0.000138	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CHRM3—nephrolithiasis	4.13e-05	0.000137	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CHRM3—nephrolithiasis	4.04e-05	0.000134	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	3.86e-05	0.000128	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APRT—nephrolithiasis	3.86e-05	0.000128	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CHRM3—nephrolithiasis	3.77e-05	0.000125	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AQP1—nephrolithiasis	3.56e-05	0.000118	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CHRM3—nephrolithiasis	3.22e-05	0.000107	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AQP1—nephrolithiasis	2.75e-05	9.13e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CHRM3—nephrolithiasis	2.49e-05	8.26e-05	CbGpPWpGaD
